|
2019:
J. de Zeeuw, A. Papakonstantinou, C. Nowozin, S.Stotz, M. Zaleska, S. Hädel, F. Bes, M. Münch, D. Kunz. (2019) Living in Biological Darkness: Objective Sleepiness and the Pupillary light responses are affected by different metameric lighting conditions during daytime. J Biol Rhythms., 34(4): 410-31. IF: 3.9
Ronald B. Postuma, Alex Iranzo, Michele Hu, Birgit Högl, Bradley F. Boeve, Raffaele Manni, Wolfgang H. Oertel, Isabelle Arnulf, Luigi Ferini-Strambi,
Monica Puligheddu, Elena Antelmi, Valerie Cochen De Cock, Dario Arnaldi,
Brit Mollenhauer, Aleksandar Videnovic, Karel Sonka, Ki-Young Jung, Dieter Kunz,
Yves Dauvilliers, Federica Provini, Simon J. Lewis, Jitka Buskova, Milena Pavlova,
Anna Heidbreder, Jacques Y. Montplaisir, Joan Santamaria, Thomas R. Barber,
Ambra Stefani, Erik K. St.Louis, Michele Terzaghi, Annette Janzen,
Smandra Leu-Semenescu, Guiseppe Plazzi, Flavio Nobili, Friederike Sixel-Doering,
Petr Dusek, Frederik Bes, Pietro Cortelli, Kaylena Ehgoetz Martens,
Jean-Francois Gagnon, Carles Gaig, Marco Zucconi, Claudia Trenkwalder,
Ziv Gan-Or, Christine Lo, Michal Rolinski, Philip Mahlknecht, Evi Holzknecht,
Angel R. Boeve, Luke N. Teigen, Gianpaolo Toscano, Geert Mayer, Silvia Morbelli,
Benjamin Dawson, Amelie Pelletier and the International REM Sleep Behavior
Disorder Study Group. (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. BRAIN 142: 744-759. IF: 10.6
2018:
A. Kawasaki, S. Wisniewski, B. Healey, N. Pattyn, D. Kunz, M. Basner, M. Münch.
(2018) Impact of long-term daylight
deprivation on retinal light
sensitivity, circadian rhythms and
sleep during the Antarctic winter. Sci Rep 8:16185. IF: 4.1
Kunz D, Bes F. (2018) Melatonin Therapy of RBD. In: Schenck C, H gl B and Videnovic A (Eds.), Rapid-Eye-Movement Sleep Behavior Disorder. Springer Nature, New York, pp: 315-331
Zeeuw J, Wisniewski S, Papakonstantinou A, Bes F, Wahnschaffe A, Zaleska M, Kunz D, Münch M. (2018) The alerting effect of the wake maintenance zone during 40 hours of sleep deprivation. Sci Rep. 20;8(1):11012. IF : 4.1
Wittenbrink N, Ananthasubramaniam B, Münch M, Koller B, Maier B, Weschke C, Bes F, de Zeeuw J, Nowozin C, Wahnschaffe A, Wisniewski S, Zaleska M, Bartok O, Ashwal-Fluss R, Lammert H, Herzel H, Hummel M, Kadener S, Kunz D, Kramer A. (2018) High-accuracy determination of internal circadian time from a single blood sample. J Clin Invest.: 120874. IF: 13.2
Scheuermeier K, Münch
M, Ronda JM and Duffy JF (2018) Improved cognitive morning performance in healthy
older adults following blue-enriched light exposure on the previous
evening. Behav Brain Res. S0166-4328(17): 31535-8. IF: 3.2
2017:
Kunz D., Bes F. (2017) Twenty Years After: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder, Using Serial Dopamine Transporter Imaging. Neuropsychobiology 2017;76:100 104. IF: 1.4
Münch M, Ladaique M, Roemer S, Hashemi
K and Kawasaki A (2017) Melanopsin-mediated acute
light responses measured in winter and in summer: seasonal variations in
adults with and without cataracts. Frontiers in Neurology
(Neuro-Ophthalmology) 8:464. IF: 3.6
Swanson C, Shea SA, Wolfe P,
Cain SW, Münch M, Vujovic N, Czeisler CA,
Buxton OM and Orwoll ES (2017) Bone turnover markers after sleep
restriction and circadian disruption: a mechanism for sleep-related bone
loss in humans. The Journal of Clinical Endocrinology and Metabolism
102(10):3722-3730. IF: 5.5
Swanson C, Shea SA, Wolfe P, Markwardt S, Cain SW, Münch
M, Czeisler CA, Orwoll ES and Buxton OM
(2017) 24-hour profile of serum sclerostin and
its association with bone biomarkers in men. Osteoporosis International
28(11):3205-13. IF: 3.6
Gaspar
L, Howald C, Popadin K,
Maier B, Mauvoisin D, Moriggi
E, Guttierez-Arcelus M, Falconnet
E, Borel C, Kunz D, Kramer A, Gachon F, Dermitzakis ET, Antonarakis SE and Brown SA (2017) The genomic
landscape of human cellular circadian variation points to a 2 novel role
for the signalosome. eLife
6: e24994. IF: 7.7
Wahnschaffe A,
Nowozin C, Rath
A, Floessner T, Appelhoff
S, Münch M and Kunz D (2017) Night-time
activity forecast by season and weather in a longitudinal design - natural
light effects on three years' rest-activity cycles in nursing home
residents with dementia. International Psychogeriatrics
29(12):2071-80. IF: 2.4
Regente J,
de Zeeuw J, Bes F, Nowozin
C, Appelhoff S, Wahnschaffe
A, Münch M and
Kunz D (2017) Can short-wavelength depleted
bright light during single simulated night shifts prevent circadian phase
shifts? Journal of Applied Ergonomics 61:22-30. IF: 1.7
Special Issue for Current
Alzheimer Research - CAR
Topic: Chronotherapeutics
in Neurodegenerative Disorders
Guest Editor: Dieter Kunz
Own contributions:
Kunz D (2017)
Editorial - Circadian rhythms are everywhere: except in neurodegenerative
disorders. Current Alzheimer Research 14(10):1018-21. IF: 3.0
Nowozin C,
Wahnschaffe A, Rodenbeck
A, de Zeeuw J, H del S, Kozakov R., Schöpp H, Münch M and Kunz D (2017) Applying melanopic
lux to measure biological light effects on melatonin suppression and subjective
sleepiness. Current Alzheimer Research 14(10):1042-52. IF: 3.0
Schäfer C,
Kunz D and Bes F (2017)
Melatonin effects in REM sleep behavior disorder associated with
obstructive sleep apnea syndrome: a case series. Current Alzheimer Research
14(10): 1084-9. IF: 3.0
Wahnschaffe A,
Nowozin C, Haedel S, Rath A, Appelhoff S, Münch M and Kunz D (2017) Implementation of dynamic lighting
in a nursing home: impact on agitation but not on rest-activity patterns.
Special Issue: Current Alzheimer Research 14(10):1076-83. IF: 3.0
Münch M., Schmieder M., Bieler K., Goldbach R., Fuhrmann T., Zumstein N., Vonmoos P., Scartezzini J-L., Wirz-Justice
A.and Cajochen C (2017)
Bright light delights: effects of daily light exposure on emotions,
rest-activity cycles, sleep and melatonin secretion in severely demented
patients. Special Issue: Current Alzheimer Research 14(10):1063-75. IF: 3.0
2016:
Münch M,
Nowozin C, Regente J,
Bes F, De Zeeuw J, H del S, Wahnschaffe
A and Kunz D (2016) Blue-enriched morning
light as a countermeasure to light at the wrong time: effects on cognition,
sleepiness, sleep, and circadian phase. Neuropsychobiology
74:207-18. IF: 1.5
Wirz-Justice
A and Münch M (2016) (Editorial for Special
Issue on Chronobiology). Neuropsychobiology 74(4):181. IF:
1.5
Maierova L, Borisuit A, Scartezzini J-L, Jaeggi S M, Schmidt C and Münch M (2016) Diurnal variations of hormonal secretion,
alertness and cognition in extreme chronotypes
under different lighting conditions. Scientific Reports 6:33591. IF: 5.2
Münch M, Kourti P, Brouzas D, Kawasaki
A (2016) Variation in the pupil light reflex between winter and summer
seasons. Acta Ophthalmol
94(3):e244-6. IF: 3.2
Lane
JM, Chang AM, Bjonnes AC, Aeschbach
D, Anderson C, Cade BE, Cain SW, Czeisler CA, Gharib SA, Gooley JJ,
Gottlieb DJ, Grant SF, Klerman EB, Lauderdale DS,
Lockley SW, Münch M, Patel S,
Punjabi NM, Rajaratnam SM, Rueger
M, St Hilaire MA, Santhi
N, Scheuermaier K, Van Reen
E, Zee PC, Shea SA, Duffy JF, Buxton OM, Redline S, Scheer
FA and Saxena R (2016) Impact of common diabetes
risk variant in MTNR1B on sleep, circadian and melatonin physiology.
Diabetes 65(6):1741-51. IF: 8.5
Borisuit A, K mpf J, Münch M, Thanachareonkit
A and Scartezzini J-L (2016) Monitoring and rendering of visual and
photo-biological properties of daylight-redirecting systems. Solar Energy 129: 297-309.
IF:4.0
2015:
Münch M,
L on L, Collomb S and Kawasaki A (2015) Comparison
of acute non-visual bright light responses in patients with optic nerve
disease, glaucoma and healthy controls. Scientific Reports 5:15185. IF: 5.6
Borisuit A, Linhart F, Scartezzini J-L and Münch
M (2015) Effects of realistic
office daylighting and electric lighting conditions on visual comfort,
alertness and mood. Lighting Research and Technology 47:192-209. IF: 1.197
2014:
Jaehne A,
Unbehaun T, Feige1 B, Cohrs
S, Rodenbeck A and Riemann D
(2014) Sleep changes in smokers before, during and 3 months after nicotine
withdrawal. Addiction Biology 20(4):747-55. IF: 5.9
Cohrs S,
Rodenbeck A, Riemann D, Szagun B, Jaehne A, Brinkmeyer J, Gr nder G, Wienker T, Diaz-Lacava A, Mobascher A, Dahmen N, Thuerauf N, Kornhuber J,
Kiefer F, Gallinat J, Wagner M, Kunz D, Grittner U and Winterer G (2014) Impaired sleep quality
and sleep duration in smokers- results from the german
multicenter study on nicotine dependence. Addiction Biology 19(3):486-96.
IF: 4.2
Cordi M,
Ackermann S, Bes FW, Hartmann F, Konrad BN, Genzel L, Pawlowski M, Steiger A,
Schulz H, Rasch B and Dresler
M (2014) On lunar cycle effects on sleep and the file drawer problem. Current
Biology 24(12):R549-50. IF: 9.5
Goerke M,
Cohrs S, Rodenbeck A and Kunz D (2014) Differential effect of
an anticholinergic antidepressant on sleep-dependent memory consolidation.
Sleep 37(5):977-85. IF: 5.1
Penzel T,
Pevernagie D, Dogas Z,
Grote L, de Lacy S, Rodenbeck A, Bassetti C, Berg S, Cirignotta
F, d'Ortho MP, Garcia-Borreguero
D, Levy P, Nobili L, Paiva T, Peigneux
P, Pollm cher T, Riemann D, Skene DJ, Zucconi M and Espie C (2014) For
The Sleep Medicine Committee and The European Sleep Research Society:
Catalogue of knowledge and skills for sleep medicine. J Sleep Res 23(2):222-38.
IF: 3.0
Münch M, Plomp
G, Thunell E, Kawasaki A, Scartezzini
JL and Herzog MH (2014) Different colors of light lead to different
adaptation and activation as determined by high-density EEG. Neuroimage 101:547-54. IF: 6.3
Cajochen C, Altanay-Ekici S, Münch M,
Frey S,
Knoblauch V
and Wirz-Justice A (2014) Reply to Cordi et al. Current Biology
24(17):R795. IF: 9.5
Münch M (2014) Der Schlaf und die innere Uhr im Alter. Therapeutische Umschau 71(11):657-62. IF:0.2
2013:
Bes F, Jobert M, Schulz H. Modeling sleep propensity when sleep is severely restricted. Sleep 2013;36(4):209-211. doi:10.5665/sleep.2558. IF: 5.8
Jobert M, Wilson FJ, Roth T, Ruigt GSF, Anderer P, Drinkenburg WHIM, Bes FW, Brunovsky M, Danker-Hopfe H, Freeman J,van Gerven JMA, Gruber G, Kemp B, Klösch G, Ma J, Penzel T, Peterson BT, Schulz H, Staner L, Saletu B, Svetnik V. Guidelines for the Recording and Evaluation of Pharmaco-Sleep Studies in Man: The International Pharmaco-EEG Society (IPEG). Neuropsychobiol 2013; 67:127-167. doi: 10.1159/000343449. IF: 2.3
Kawasaki A, Collomb S, L on L and Münch
M (2013) Pupil responses derived from outer and inner retinal
photoreception are normal in patients with hereditary optic neuropathy. Exp
Eye Res 120C:161-166. IF: 3.0
Dauvilliers Y,
Bassetti C, Lammers GJ,
Arnulf I, Mayer G, Rodenbeck
A, Lehert P, Ding CL, Lecomte
JM and Schwartz JC; for the HARMONY I study group (2013) Pitolisant versus placebo or modafinil
in patients with narcolepsy: a double-blind, randomised
trial. Lancet Neurol 10:1068-75. IF: 23.9
Cajochen C,
Altanay-Ekici S, Münch
M, Frey S, Knoblauch V and Wirz-Justice A
(2013) Evidence that the lunar cycle influences human sleep. Curr Biol 23(15):1485-8. IF:
9.5
Putilov
AA, Münch MY and Cajochen C (2013) Principal component structuring of
the Non-REM Sleep EEG spectrum in older adults yields age-related changes
in the sleep and wake drives. Curr Aging Sci 6(3):280-93. IF: 2.9
Schlack R, Hapke U,
Maske U, Busch M A and Cohrs S (2013) H ufigkeit
und Verteilung von Schlafproblemen und Insomnie in der deutschen
Erwachsenenbev lkerung. Bundesgesundheitsbl 56:740-748. IF: 0.7
Wahnschaffe A, Haedel S, Rodenbeck
A, Stoll C, Rudolph H, Kozakov R, Schöpp H and Kunz D (2013) Out of the lab into
the bathroom: Evening short-term exposure to conventional light suppresses
melatonin and increases alertness perception. Int
J Mol Sci 14:2573-2589.
IF: 2.6
Goerke M, Cohrs S, Rodenbeck
R and Kunz K (2013) The influence of the tricyclic
antidepressant amitriptyline on periodic limb movements during sleep. Pharmacopsychiatry 46(3):108-13. IF: 2.1
Kunz
D (2013) Melatonin in rapid eye
movement sleep behavior disorder: why does it work? Sleep Medicine 14:705-706.
IF: 3.4
2012:
Spörl F,
Korge S, Jürchott K, Wunderskirchner M, Schellenberg
K, Heins S, Specht A, Stoll C, Klemz R, Maier B, Wenck H,
Schrader A, Kunz D, Blatt T
and Kramer A (2012) Kr ppel-like factor 9 is a
circadian transcription factor in human epidermis that controls
proliferation of keratinocytes. PNAS 109:10903-8. IF: 9.8
Goerke M,
Cohrs S, Rodenbeck A, Grittner U, Sommer W and Kunz
D (2012) Declarative memory consolidation during the first night in a
sleep lab - The role of REM sleep and cortisol. Psychoneuroendocrinology
38(7):1102-11. IF: 5.2
Kunz
D, Bineau S, Maman K, Milea D and Tourni M (2012) Benzodiazepine
discontinuation with prolonged-release melatonin: hints from a German
longitudinal prescription database. Expert Opin Pharmacother 13(1):9-16. IF: 2.4
Hoever P,
Dorffner G, Bene H,
Penzel T, Danker-Hopfe
H, Barbanoj MJ, Pillar G, Saletu
B, Polo O, Kunz D, Zeitlhofer J, Berg S, Partinen M, Bassetti CL, H gl B, Ebrahim IO, Holsboer-Trachsler E, Bengtsson
H, Peker Y, Hemmeter
U-M, Chiossi E, Hajak G
and Dingemanse J (2012) Orexin Receptor
Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical
Trial. Clinical Pharmacology
& Therapeutics 92(6):975-985. IF: 6.4
Kunz D(2012) Schlafstörungen und Depression: Melatonin taktet die innere
Uhr neu. Neurologie & Psychiatrie 14(1) (CME-Fortbildung 01/2012)
2011:
Rodenbeck A (2011) Biologische Grundlagen des Schlafens und Wachens. Bundesgesundheitsblatt
54:1270-5. IF:0.7
2010:
Kozakov R, Schöpp H, Franke St,
Stoll C and Kunz D (2010) Modification of light sources for
appropriate biological action. Journal of Physics D: Applied Physics 43:234007.
IF: 2.6
Kunz D
and Mahlberg R (2010) A two-part,
double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 19(4):591-6. IF: 3.4
Cohrs S, Gade K, Meier A, Jordan W, Falkai
P, Röther E and Rodenbeck
A (2010) Quetiapine improves sleep disturbance in acute bipolar
disorder: a case series. Pharmacopsychiatry.
43(4):154-5. IF: 2.1
Jähne A, Cohrs S,
Rodenbeck A, Andreas S, Loessl B, Feige B, Kloepfer C, Hornyak M,
Riemann D (2010) Nikotin. Einfluss auf den Schlaf und
Relevanz für Psychiatrie und Psychotherapie.Nervenarzt
81(7):844-59. IF: 0.7
Rodenbeck A, Hajak
G (2010): Das Schichtarbeitersyndrom. Eine systematische Übersicht zu
Schlafstörungen durch Schichtarbeit. Somnologie 14(2):105-10. IF: 0.2
Hajak G, Rodenbeck
A (2010): Medikamentöse Therapie des
Schichtarbeitersyndroms. Somnologie 14(2): 111-22. IF: 0.2
2009:
Gunga H-C, Werner A, Stahn A,
Steinach M, Schlabs T, Koralewski E and
Kunz D (2009) The Double Sensor - A non-invasive device to
continuously monitor core temperature in humans on earth and in space. Respir Physiol
Neurobiol 169 Suppl 1:63-8. IF: 2.1
Alpay G, Goerke M
and Sturmer B (2009) Precueing
imminent conflict does not override sequence-dependent interference
adaptation. Psychological
Research-Psychologische Forschung 73: 803-16. IF: 1.36
G.
Mayer, I Fietze, Fischer J, Penzel T, Riemann D, Rodenbeck A, Sitter H and
Teschler H (2009). S3 Leitlinie Nicht erholsamer
Schlaf/Schlafstörungen. Somnologie 13 Suppl4:160.
IF: 0.8
Bodenmann
S, Rusterholz T, Dörr R, Stoll C, Bachmann
V, Geissler E, Jaggi-Schwarz K and Landolt H-P (2009) The functional Val158Met polymorphism
of COMT predicts interindividual
differences in brain alpha oscillations in young men. J Neuroscience 29:10855-62. IF: 7.2
Cohrs S (2009) Genese
schlafassoziierter forensisch-relevanter Störungen. In: Müller, Jürgen,
Peter (Hrsg.) Neurobiologie forensisch-relevanter Störungen, Kohlhammer,
Stuttgart, S: 231-8
Rodenbeck A, Cohrs S and Zerr I (2009) Letale familiäre Insomnie. In: Happe
S; Walther BW (Hrsg.) Schlafmedizin in der Praxis. Die internationale
Klassifikation von Schlafstörungen in Fallberichten, ECOMED Medizin,
Heidelberg, S: 355-60
Mahlberg R, Kienast T, Haedel S,
Heidenreich JO, Schmitz S and Kunz D
(2009) Degree of Pineal Calcification (DOC) is associated with
polysomnographic sleep measures in primary insomnia patients. Sleep
Med 10(4):439-45. IF: 3.7
2008:
Brown SA1, Kunz D,
Dumas A, Westermark PO, Vanselow
K, Tilmann-Wahnschaffe
A, Herzel
H and Kramer A (2008) Molecular insights into human daily behavior. Proc Natl Acad
Sci USA 105(5):1602-7. IF: 9.4
Mahlberg R,
Walther S, Kalus P, Bohner
G, Haedel S, Reischies
FM, K hl KP, Hellweg R
and Kunz D (2008) Pineal calcification in Alzheimer's disease: An in
vivo study using computed tomography. Neurobiol
Aging 29:203-209.
IF: 4.4
Wedekind D,
Preiss B, Cohrs
S, Röther E, Huether
G, Adler L (2008) Relationship between nocturnal urinary cortisol excretion
and symptom severity in subgroups of patients with depressive episodes. Neuropsychobiology 56:119-22. IF: 1.9
Cohrs S
(2008): Sleep disturbances in patients with schizophrenia: impact and effect
of antipsychotics. CNS Drugs 22:939-962. IF: 3.8
Rodenbeck A, Cohrs S (2008)
Psychoneuroendokrinologie der Insomnie - Der Circulus vitiosus
der psychophysiologischen Insomnie auf psychologischer,
elektrophysiologischer und endokriner Ebene. Psychoneuro
34:63-68. IF: 5.2
Cohrs S, Rodenbeck A,
Hornyak M, Kunz D (2008) Restless legs syndrom, periodische Gliedma enbewegungen
im Schlaf und Psychopharmakologie, Nervenarzt 79:1263-72. IF: 0.82
2007:
Gallinat J
and Kunz D, Lang UE, Neu P, Kassim N, Kienast T, Seifert
F, Schubert Fand Bajbouj
M (2007) Association between cerebral glutamate and human behaviour: The sensation seeking personality trait. Neuroimage 34:671-67. IF: 1.2
Mahlberg R
and Kunz D (2007) Relationship of melatonin excretion levels to
polysomnographic sleep parameters in healthy subjects and patients with
sleep related disturbances. Sleep Medicine 8:512-6. IF: 1.4
Mahlberg R,
Walther S, Eichmann U, Tracik F and Kunz
D (2007) Effects of rivastigmine on actigraphically monitored motor activity in severe
agitation related to Alzheimer s Disease: A placebo-controlled pilot study.
Arch Gerontol Geriatr
45:19-26. IF: 2.0
Montag
C, Heinz A, Kunz D, Gallinat J (2007).
Self-reported empathic abilities in schizophrenia. Schizophrenia Res.
92:85-89. IF: 2.4
2006:
Benes
H, Deissler A, Rodenbeck
A, Engfer A and Kohnen
R (2006) Lisuride treatment of restless legs
syndrome: First studies with monotherapy in de novo patients and in
combination with levodopa in advanced disease. J Neural Transm
113:87-92. IF: 3.1
Cohrs S, Röher C, Jordan W, Meier A, Huether
G, Wuttke W, Röther E
and Rodenbeck A (2006) The atypical
antipsychotics olanzapine and quetiapine but not haloperidol reduce ACTH
and cortisol. Psychopharmacology 185(1):11-18. IF: 4.4
Gallinat J,
Kunz D, Senkowski D, Kienast
T, Seifert F. Schubert F and Heinz A (2006) Hippocampal glutamate
concentration predicts cerebral theta oscillations. Psychopharmacology 187:103-11. IF:
3.6
Jordan
W, Cohrs S, Degner
D, Meier A, Rodenbeck A, Mayer G, Pilz J, Röther E, Kornhuber J and Bleich S
(2006) Evaluation of oxidative stress measurements in obstructive sleep
apnea syndrome. J Neural Transm 113:239-254. IF: 2.2
Kluge
M, Schussler P, Weikel
J, Dresler M, Zuber V, Querfurt
F, Yassouridis A and Steiger
A (2006) Altered nocturnal growth hormone (GH) secretion in obsessive
compulsive disorder. Psychoneuroendocrinology 31:1098-104.
IF: 5.5
Mahlberg R, Tilmann A, Salewski
L and Kunz D (2006) Normative data on the daily profile of urinary
6-sulfatoxymelatonin in healthy subjects between the ages 20 and 84. Psychoneuroendocrinology 31: 634-41. IF: 5.5
Müller
B, Gäbelein WD, Schulz H (2006) A
taxonomic analysis of sleep stages. Sleep 29:967-74. IF: 2.0
Rodenbeck A, Binder
R, Geisler P, Danker-Hopfe H, Lund R, Raschke F, Wee HG and Schulz
H (Task Force "Scoring of Polysomnographic Recordings" of the
German Sleep Society [DGSM]) (2006) A Review of Sleep EEG Patterns. Part 1:
A compilation of amended rules for their visual recognition according to Rechtschaffen and Kales. Somnologie
10:159-175. IF: 0.8
Schmid
DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel
JC, Sonntag A and Steiger A (2006) Changes of
sleep architecture, spectral composition of sleep EEG, the nocturnal
secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin and leptin
and the DEX-CRH-test in depressed patients during treatment with
mirtazapine. Neuropsychopharmacology 31 (4):832-844.
IF: 3.7
Schmitz S, Heidenreich JO, Platzek I, Kunz D, Mahlberg
R and Wolf
KJ (2006). Computed tomography of the human pineal gland for
study of the sleep-wake rhythm: Reproducibility of a semi-quantitative
approach. Acta Radiologica 47:865-871. IF: 1.1
Schmidt
H, Cohrs S, Heinemann T, Goerdt C, Djukic M, Heimann B, Wallesch CW and Nau R (2006) Sleep disorders are long-term sequelae of
both bacterial and viral meningitis. J Neurol Neurosurg & Psychiatry 77(4):554-558. IF: 2.2
Walther
S, Mahlberg R, Eichmann U and
Kunz D (2006) Delta-9-tetrahydrocannabinol for night-time agitation
in severe dementia. Psychopharmacology 185:524-8. IF: 4.4
2005:
Anderer P,
Gruber G, Parapatics S, Woertz M, Miazhynskaia T, Klösch G, Saletu B, Zeitlhofer J, Barbanoj MJ, Danker-Hopfe H, Himanen SL, Kemp B, Penzel T,
Gr zinger M, Kunz D, Rappelsberger
P, Schlögl A and Dorffner
G (2005) An E-health solution for automatic sleep classification according
to Rechtschaffen and Kales: validation study of
the Somnolyzer 24x7 utilizing the Siesta database.
Neuropsychobiology 51:115-33. IF:1.9
Cohrs S,
Meier A, Neumann AC, Röther E and Rodenbeck A (2005) Improved sleep
continuity and increased slow wave sleep and REM latency during ziprasidone
treatment: a randomized, controlled, crossover trial of 12 healthy male
subjects. J Clin Psychiatry 66:989-96. IF: 3.7
Gallinat J,
Kunz D, Lang UE, Kalus P, Juckel G, Mahlberg
R, Eggers T, Wernicke C, Rommelspacher H and Smolka MN (2005) Serotonergic effects of smoking are
independent from the human serotonin transporter gene promoter
polymorphism: Evidence from auditory cortical stimulus processing. Pharmacopsychiatry 38:158-60. IF: 0.9
Happe S,
Klösch G, Lorenzo J, Kunz D, Penzel T, Röschke J, Himanen SL, Gruber and Zeitlhofer
(2005) Perception of sleep: Subjective versus objective sleep parameters in
patients with Parkinson disease in comparison with healthy elderly
controls. J Neurology 252:936-43. IF: 3.0
Hornyak M,
Kopasz M, Rodenbeck
A, Hajak G, Riemann D and Voderholzer
U (2005) Influence of low-dose doxepin on periodic leg movements in sleep
in primary insomnia patients. Somnologie 9:111-5.
IF: 0.8
Jordan
W, Reinbacher A, Cohrs
S, Grunewald RW, Mayer G, Röther E and Rodenbeck A (2005) Obstructive sleep apnea: Plasma
endothelin-1 precursor but not endothelin-1 levels are elevated and decline
with nasal continuous positive airway pressure. Peptides 26:1654-60. IF:
2.6
Jordan
W, Tumani H, Cohrs
S, Rodenbeck A, Röther E, Bechthold J and Mayer
G (2005) Narcolepsy: Increased L-PGDS (-trace) levels correlate with
excessive daytime sleepiness but not with cataplexy. J Neurol
252:1372-8. IF: 3.0
Kalus P,
Slotboom J, Gallinat J,
Mahlberg R, Cattapan-Ludewig
K, Nyffeler T, Buri C, Federspiel A, Kunz D, Schroth
G and Kiefer C (2005) Examining the gateway to the limbic system with diffusion
tensor imaging: The perforant pathway in dementia.
Neuroimage 30:713-20. IF: 5.2
Lang
UE, Hellweg R, Bajbouj
M, Lenzen KP, Sander T, Kunz D and Gallinat J (2005) Association of a functional BDNF
polymorphism and anxiety-related personality traits. Psychopharmacology
180:95-9. IF: 4.4
Meier
A, Mollenhauer B, Cohrs
S, Rodenbeck A, Jordan W, Meller J and Otto M (2005) Normal hypcretin-1
(Orexin-A) levels in the cerebrospinal fluid of patients with huntington s disease. Brain Res 1063:201-3. IF: 1.9
Meier
A, Neumann A-C, Jordan W, Huether G, Rodenbeck A, Röther
E and Cohrs S (2005) Ziprasidone
reduces cortisol excretion in healthy subjects. Br J Pharmacol
60:330-6. IF: 3.1
Rodenbeck A, Hajak G, Meier A, Cohrs
S and Jordan W (2005) Psychoneuroendokrine Pathomechanismen der psychophysiologischen
Insomnie. Somnologie
9:21-32. IF: 0.5
Schmid
DA, Held K, Ising M, Uhr
M, Weikel JC and Steiger A (2005) Ghrelin stimulates appetite, imagination
of food, GH, ACTH, and cortisol, but does not affect leptin in normal
controls. Neuropsychopharmacology 30(6):1187-92.
IF: 3.7
2004:
Cohrs S, Guan Z, Pohlmann K, Jordan W, Pilz J, Röther E and Rodenbeck A (2004)
Nocturnal urinary dopamine excretion is reduced in
otherwise healthy subjects with periodic leg movements in sleep. Neurosci Lett 360(3):161-4. IF: 2.3
Cohrs S, Pohlmann K, Guan Z, Jordan W, Meier A, Huether G, Röther E and Rodenbeck A (2004) Quetiapine reduces
nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology
174:414-420. IF: 3.2
Cohrs S, Rodenbeck A, Guan Z, Pohlmann
K, Jordan W, Meier A and Röther E (2004)
Sleep-promoting properties of quetiapine in healthy subjects.
Psychopharmacology 174(3):421-9. IF: 3.2
Danker-Hopfe H, Kunz D, Gruber G, Klösch
G, Lorenzo JL, Himanen SL, Kemp B, Penzel T, Röschke J, Dorn H,
A Schlögl A, Trenker A
and Dorffner G (2004) Interrater reliability
between scorers from eight european sleep labs in
subjects with different sleep disorders. J Sleep Res 13:63-9. IF: 2.9
Jordan
W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann
PD, Von Ahsen N, Röther
E, Kornhuber J and Bleich
S (2004) CPAP-therapy effectively lowers serum homocysteine in obstructive
sleep apnea syndrome. J Neural Transm 111(6):683-9.
IF: 3.1
Jordan
W, Tumani H, Cohrs
S, Eggert S, Rodenbeck A,
Brunner E, Röther E and Hajak
G (2004) Prostaglandin-D-synthase (beta-trace) in healthy human sleep.
Sleep 27: 867-74. IF: 1.2
Kirov
R, Kinkelbur J, Heipke
S, Kostanecka-Endress T, Westhoff
M, Cohrs S, Röther
E, Hajak G, Banaschewski
T and Rothenberger A (2004) Is there a specific
polysomnographic sleep pattern in children with attention deficit/hyperactivity
disorder? J Sleep Res 13:87-93. IF: 1.4
Kunz D, Mahlberg
R, Müller C, Tilmann A, Bes F (2004) Melatonin in patients
with reduced REM sleep duration: Two randomized controlled trials. J Clin Endocrinol Metab 89:128-34. IF: 5.5
Kunz D (2004) Chronobiotic
protocol and circadian sleep propensity index: New tools for clinical
routine and research on melatonin and sleep. Pharmacopsychiatry 37:139-46. IF: 3.2
Mahlberg R, Kunz
D, Sasse J and Kirchheiner
J (2004) Serotonine syndrome with tramadol and
citalopram in a patient heterozygous for deficient CYP2D6 and CYP2C19
alleles. Am J Psych 161:1129. IF: 4.7
Mahlberg R, Kunz
D, Sutej I, Kühl KP
and Hellweg R (2004) Melatonin treatment of
day-night rhythm disturbances and sundowning in
Solution for Automatic Sleep disease: An open-label pilot study using actigraphy. J Clin Psychopharmacol
(IF: 4.6) 24:456-9. IF: 3.1
Anmerkungen:
Publikationen vor Gründung der AG 2004 sowie
Buchartikel etc. finden sich im Anschluss an die individuellen CVs.
IF
bezeichnet den Impact-Faktor zum Zeitpunkt der Publikation.
|
